Microparticles in the air of industrial cities as a risk factor of bronchial asthma
https://doi.org/10.31089/1026-9428-2020-60-11-870-872
Abstract
Introduction. Suspended particles in ambient air of cities increase the risk of developing respiratory and cardiovascular diseases. At the same time, data on the role of suspended particles in the formation and complication of the course of bronchial asthma (BA) are extremely limited.
The aim of study was to substantiate the design of a study to study the effect of fine suspended particles in atmospheric air on the development of the T2 endotype of BA. The design of a "case-control" study was developed and implemented, including patients with the T2-endotype of BA and persons in the control group. In order to verify the diagnosis of BA, General clinical methods of examination and specific allergological examination are used.
In parallel, the quantitative characteristics and qualitative composition of suspended particles in atmospheric air are studied with the determination of the mass of suspended particles, dispersion, chemical and microbiological (muldi-tof mass spectrometry, PCR analysis) composition. Atmospheric air samples will be collected using a cascade impactor in the area where patients with bronchial asthma and control groups live. For each fraction, the following will be analyzed: suspended particle mass, dispersion, chemical and microbiological (muldi-tof mass spectrometry, PCR analysis) composition.
Conclusions. The study will assess the risk of T2-endotype formation of bronchial asthma with various quantitative and qualitative characteristics of suspended microparticles in the atmospheric air.
About the Authors
Milyausha R. Khakimova
Kazan state medical university
Russian Federation
Russian Federation
Resident of the Department of clinical immunology with allergology, Kazan State Medical University.
e-mail: mileushe7@gmail.com
Gulnaz F. Gabidinova
Kazan state medical university
Russian Federation
Russian Federation
References
1. Institute for Health Metrics and Evaluation. https://vizhub.healthdata.org/gbd-compare (Accessed 31.08.2020).
2. Shima M. Health Effects of Air Pollution: A Historical Review and Present Status. Nihon Eiseigaku Zasshi. 2017; 72(3): 159–65. https://doi.org/10.1265/jjh.72.159
3. Global Initiative for Asthma. GINA 2019. https://ginasthma.org
4. Avdeev S.N., Nenasheva N.M., Zhudenkov K.V., Petrakovskaya V.A., Izyumova G.V. Prevalence, morbidity, phenotypes and other characteristics of severe bronchial asthma in Russian Federation. Pulmonologiya. 2018; 28(3): 341–58. https://doi.org/10.18093/0869-0189-2018-28-3-341-358 (in Russian).
5. Ilina N.I., Nenasheva N.M., Avdeev S.N., и др. Algorithm of biophenotyping and choice of medication for targeted therapy of severe uncontrolled asthma with eosinophilic type of airways inflammation. Rossijskij allergologicheskij zhurnal. 2017; 14 (3): 5–18. https://doi.org/10.36691/RJA308 (in Russian).
Review
For citations:
Khakimova M.R., Gabidinova G.F. Microparticles in the air of industrial cities as a risk factor of bronchial asthma. Russian Journal of Occupational Health and Industrial Ecology. 2020;60(11):870-872. (In Russ.) https://doi.org/10.31089/1026-9428-2020-60-11-870-872
Views:
340
Email this article 
